These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 776718)

  • 41. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 42. [Interferon production during interaction between lymphocytes and L cell targets in different stages of the mitotic cycle].
    Nemirovskaia BM; Leneva NV
    Biull Eksp Biol Med; 1980 Mar; 89(3):342-4. PubMed ID: 6155951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells.
    Lukacs K; Kurlander RJ
    J Immunol; 1989 Dec; 143(11):3731-6. PubMed ID: 2479688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 46. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 48. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
    Kim TS; Jung MY; Cho D; Cohen EP
    Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of levamisole on the cytotoxic activity of normal lymphocytes in tissue culture].
    Chumakova MM; Kadagidze ZG
    Biull Eksp Biol Med; 1979 Nov; 88(11):581-2. PubMed ID: 540153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development of a cellular immune response in a highly cancer-susceptible C3H/He strain of mice and its nonfactor substrain C3H/f after the transplantation of a syngeneic mammary gland tumor].
    Razvorotneva VA; Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Gruntenko EV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):68-73. PubMed ID: 228516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of "eclipsed" lymphoid cells from advanced tumor-bearing mice through adoptive transfer to sublethally irradiated syngeneic hosts.
    Youn JK; Le Francois D; Hue G; Santillana M; Barski G
    Int J Cancer; 1975 Oct; 16(4):629-38. PubMed ID: 1176209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Localized irradiation on tumors and immune cell reactions--histoenzymatic evaluation using MM 46 tumor and Ehrlich tumor-bearing C3H/He mice].
    Imanaka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):355-69. PubMed ID: 6866746
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative effect of local radiotherapy and surgery on cell-mediated immunity against a mouse transplantable mammary tumor.
    Le François D; Troise GD; Chavaudra N; Malaise EP; Barski G
    Int J Cancer; 1974 May; 13(5):629-39. PubMed ID: 4843877
    [No Abstract]   [Full Text] [Related]  

  • 54. Cell-mediated immune response of patients with meningiomas defined in vitro by a [3H]proline microcytotoxicity test.
    Pees HW; Seidel B
    Clin Exp Immunol; 1976 May; 24(2):310-6. PubMed ID: 1277580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Target cells of human adenovirus type 12 in subtentorial brain tissue of newborn mice. II. Cytomorphologic and immunofluorescent microscopic studies in vitro.
    Sonobe H
    Acta Med Okayama; 1976 Aug; 30(4):277-90. PubMed ID: 137655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of immune lymphocytes on reaggregation of fetal mouse tissues.
    Szulman AE; Johnson MH
    J Anat; 1978 Oct; 127(Pt 2):273-6. PubMed ID: 721689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-mediated "immunostimulation" induced by mammary tumour virus-free Balb-c mammary tumours.
    Medina D; Heppner G
    Nature; 1973 Mar; 242(5396):329-30. PubMed ID: 4699052
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence for non-exposed H-2 antigens in immunoresistant murine tumour.
    Friberg S; Lilliehöök B
    Nat New Biol; 1973 Jan; 241(108):112-4. PubMed ID: 4512450
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of cell proliferation rather than of cell lysis as a measure of immune reactivity in embryo-antigen-challenged mice.
    Gorczynski RM; MacRae S
    Br J Cancer; 1981 Jan; 43(1):19-31. PubMed ID: 7459234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An in vitro assay of cell-mediated cytotoxicity. Terminal labeling with 3h-leucine.
    Schechter B; Feldman M
    Transplantation; 1976 Oct; 22(4):337-44. PubMed ID: 62427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.